Protagonist Therapeutics Initiates Phase 2b Study of Oral Drug Candidate PTG-100 in Ulcerative Colitis Tuesday, January 17, 2017 MILPITAS,... ...https://www.pharmafocusasia.com/pressreleases/protagonist-therapeutics-initiates-phase-2b-study-of-oral-drug-candidate-ptg-100-in-ulcerative-colitis
Shionogi Announces Positive Top-Line Results For Cefiderocol Pivotal cUTI Clinical Trial Thursday, January 12, 2017 OSAKA, Japan and FLORHAM... ...https://www.pharmafocusasia.com/pressreleases/shionogi-announces-positive-top-line-results-for-cefiderocol-pivotal-cuti-clinical-trial
InVivo Therapeutics Announces INSPIRES 29th Clinical Site: Rhode Island Hospital Tuesday, January 10, 2017 CAMBRIDGE, Mass.--( BUSINESS WIRE... ...https://www.asianhhm.com/pressreleases/invivo-therapeutics-announces-inspire-s-29th-clinical-site-rhode-island-hospital
/PRNewswire/ -- Research and Markets has announced the addition of the "Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 -... ...http://in.advfn.com/news_Anti-hypertensive-Therapeutics-in-Asia-Pacific-Mar_73562200.html
GlobeNewswire 2017-01-06 Company Reiterates Guidance for GLOBE Interim Analysis to Occur in Mid-2017 and Final Analysis in Early 2018 TEL... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=150064
Adding more life to your treasured...
Giving the true colors to your imaged...
ItâÂ€Â™s the true color of life that...